Aurocare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 1.00 M
as on 16-12-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.29 Cr
as on 16-12-2024
- Satisfied Charges ₹ 1.83 M
as on 16-12-2024
- Revenue 18.23%
(FY 2022)
- Profit 2.29%
(FY 2022)
- Ebitda 9.74%
(FY 2022)
- Net Worth 29.88%
(FY 2022)
- Total Assets 11.53%
(FY 2022)
About Aurocare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.29 Cr. The company has closed loans amounting to ₹1.83 M, as per Ministry of Corporate Affairs (MCA) records.
Rajkumar Shah, Shivani Patel, and Rajendra Patel serve as directors at the Company.
- CIN/LLPIN
U24233GJ2004PTC044672
- Company No.
044672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aurocare Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Shah  | Director | 27-Mar-2024 | Current |
| Shivani Patel | Director | 27-Jul-2009 | Current |
| Rajendra Patel | Director | 31-Aug-2004 | Current |
Financial Performance of Aurocare Lifesciences.
Aurocare Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.23% increase. The company also saw a slight improvement in profitability, with a 2.29% increase in profit. The company's net worth Soared by an impressive increase of 29.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurocare Lifesciences?
In 2019, Aurocare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jan 2024 | ₹0.38 M | Open |
Others Creation Date: 23 May 2023 | ₹1.31 M | Open |
Others Creation Date: 03 Mar 2023 | ₹7.03 M | Open |
How Many Employees Work at Aurocare Lifesciences?
Unlock and access historical data on people associated with Aurocare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurocare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurocare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
